MoneyWorks4Me

Cipla - Quaterly Results

29 Oct 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 47750.30 millions grew by 12.77 % from Rs. 42344.40 millions.Net Profit recorded in the quarter ended September 2024 rise to 28.68% to Rs. 11781.60  millions  compared to R. 9155.40 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 17271.80 millions from 14304.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 47750.30 42344.40 12.77 92760.80 81563.40 13.73 165743.40 143453.40 15.54
Other Income 2891.40 2050.90 40.98 5026.60 3630.70 38.45 10706.60 4567.90 134.39
PBIDT 17271.80 14304.70 20.74 33005.60 26646.60 23.86 55548.10 38096.80 45.81
Interest 30.00 66.10 -54.61 80.70 69.20 16.62 202.50 222.70 -9.07
PBDT 17241.80 14238.60 21.09 32924.90 26577.40 23.88 55345.60 36015.10 53.67
Depreciation 1457.10 1798.10 -18.96 2835.70 3157.60 -10.19 5875.90 5959.10 -1.40
PBT 15784.70 12440.50 26.88 30089.20 23419.80 28.48 49469.70 30056.00 64.59
TAX 4003.10 3285.10 21.86 7748.20 6275.60 23.47 12327.80 8615.40 43.09
Deferred Tax -64.20 -13.00 393.85 101.70 -102.50 -199.22 60.90 -400.90 -115.19
PAT 11781.60 9155.40 28.68 22341.00 17144.20 30.31 37141.90 21440.60 73.23
Equity 1615.10 1614.70 0.02 1615.10 1614.70 0.02 1614.70 1614.30 0.02
PBIDTM(%) 36.17 33.78 7.07 35.58 32.67 8.91 33.51 26.56 26.20
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..